Catalent Pharma Solutions
14 Schoolhouse Road
Somerset, NJ 08873
T : +1-888-SOLUTION (USA)
T : 00800 88 55 6178 (Europe/RoW)


Corporate Description

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has the proven expertise, superior technologies and flexible solutions at the right scale to help ensure successful product development, launch, tech transfer and reliable global supply.

Catalent has built this expertise through helping partners of all sizes, from the smallest innovators to the largest of biopharmaceutical leaders, to advance thousands of molecules through each phase of development and on to commercial supply. By arranging our expertise, capabilities, technologies and capacity, we provide services from specific, tailored program support or comprehensive, integrated solutions that are fast, flexibility, reliable and that help our partners reduce project risk. In fact, our team of nearly 13,000 at more than 35 sites develop more than 700 projects and help launch in excess of 200 products every year. We produce more than 72 billion doses of over 7,000 products for more than 1,000 customers – or 1 in 20 doses taken by patients globally. Our passion is to help unlock the full potential of your product.

More products better treatments reliably supplied™



Technology Highlights

With our wide range of expert services—including analytical, biologics, preformulation, and formulation—we drive faster, more efficient development timelines and produce better products. These include:



  • Paragon Gene Therapy, part of Catalent Biologics, focuses on transformative technologies, including adeno-associated virus (AAV) gene therapies, next-generation vaccines, and oncology immunotherapies.
  • GPEx® Boost technology for advanced cell expression, and advanced biopharmaceutical development, analytical and manufacturing.
  • SMARTag® technology for antibody-drug conjugation, affording precision design of next-generation biologic therapies.
  • OneBioSM Suite, a single solution from cell line development through clinical supply reduces timelines, risk and complexity.
  • OptiForm® Solution Suite to assist in rapid, optimized dose form development.
  • Bioavailability enhancement including lipid-based systems, Pharmatek SDTM spray dry technology, particle-size engineering, and OptiMelt® hot melt extrusion.
  • Unique delivery technologies: including OptiShell® gelatin-free capsule technology, the Zydis® orally disintegrating tablet platform, and controlled release dose design, as well as inhaled and injectable dose forms.
  • Catalent R.P. Scherer Softgel is a global leader in innovative oral and topical softgel technologies, and nearly 90% of NCEs approved by the FDA over the last 25 years have been developed by us.